AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...
The modern business landscape is evolving rapidly, with new challenges and opportunities shaping the way entrepreneurs build and scale their ventures. In 2025, success requires a combination of ...
AI agents aren’t meant to take human jobs—instead they free humans from their most tedious tasks and allow them to focus on ...
Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...
Get an overview of the 2025 AI Decision Brief, a Microsoft report on how generative AI is impacting businesses and how to ...
Signs an Amended & Restated License Agreement for Multiple Technologies for Gene Therapy for Type 1 and Type 2 Diabetes Forms a Wholl ...